New combination cholesterol drug, Liptruzet by Merck, has received approval by FDA. This drug helps in lowering a patient’s low-density lipoprotein (LDL) cholesterol levels.
![Merck’s Combination Cholesterol Drug Liptruzet Gets FDA Nod Merck’s Combination Cholesterol Drug Liptruzet Gets FDA Nod](https://www.medindia.net/afp/images/Health-children-drugs-Australia-189260.jpg)
The FDA has approved the use of this drug to treat elevated LDL levels especially in cases where diet and lifestyle changes have not helped in making a difference to “bad cholesterol” levels.
The company said this combination pill is a boon for patients whose earlier attempts at lowering cholesterol had not worked. The dosage for the drug is usually one per day with a dosage range of 10/10 mg/day through 10/80 mg/day. Liptruzet may cost $5.50 per pill as per the list price of the company.
Every 1% reduction in your cholesterol level lowers your risk of heart disease by 2%. Each increase of 1 mg/dL (not percent) of your good cholesterol decreases your risk 2-3%.
Source-Medindia